SeaStar Medical Holding Corporation Warrant financials
$0.0154−6.10%
Close Sep 25, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 |
|---|---|---|---|---|
| Revenue | $1.2M | $135.0K | $0.00 | $0.00 |
| Gross profit | $1.2M | $135.0K | $0.00 | $0.00 |
| Gross margin | 95.7% | 100.0% | — | — |
| Operating income | -$12.2M | -$17.8M | -$14.2M | -$11.6M |
| Net income | -$12.2M | -$24.8M | -$26.2M | -$12.2M |
| Net margin | −984.6% | −18392.6% | — | — |
| Diluted EPS | $-5.86 | $-66.33 | $-302.60 | $-370.00 |
| EBITDA | -$12.2M | -$17.8M | -$14.2M | -$11.6M |
| Operating cash flow | -$13.6M | -$16.0M | -$10.3M | -$7.8M |
| Free cash flow | -$13.6M | -$16.0M | -$10.3M | -$7.8M |
| Diluted shares | 2.1M | 0.4M | 0.1M | 0.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $12.0M | $1.8M | $176.0K | $47.0K |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $525.0K | $574.0K | $9.1M | $8.8M |
| Total assets | $14.2M | $4.7M | $3.5M | $3.0M |
| Total liabilities | $3.7M | $6.8M | $17.4M | $23.8M |
| Shareholders' equity | $10.4M | -$2.2M | -$13.9M | -$20.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology